tradingkey.logo

Revolution Medicines dips after AbbVie denies takeover talks

ReutersJan 8, 2026 10:31 AM

Shares of Revolution Medicines RVMD.O down 9.8% at $92.60 premarket after AbbVie ABBV.N denies takeover talks

ABBV says “not in discussions with Revolution Medicines” after WSJ report of advanced deal talks; RVMD declines to comment on speculation

RVMD stock had closed at an all-time high after WSJ's report and logged its biggest daily gain of 30% on record

WSJ had reported a potential valuation of $20 bln+ including premium

RVMD market value before the WSJ report was about $15.4 bln

RVMD gained over 82% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI